dm+d
86977007
Articles
Example medicines to prescribe by brand name in primary care
27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Differences in oral tablet mesalazine preparations and considerations when switching
19 October 2021An overview of differences between mesalazine tablet preparations and clinical considerations when switching between preparations.
Safety in lactation: Drugs for chronic bowel disorders
21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
Medicine Compliance Aid Stability
Mezavant XLShire Pharmaceuticals Ltd
Shire Pharmaceuticals Ltd
Mezavant XL
Tablets e/c m/r 1.2g
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light. SPC states store in original packaging.
22 October 2015
Asacol MRWarner Chilcott UK Ltd
Warner Chilcott UK Ltd
Asacol MR
Tablets e/c 400mg, 800mg
G1 · Green 1Stability data indicates that the drug is suitable for CAs and there are no theoretical concerns with the product.
Airtight container
Protect from light
If the desiccant is removed, or the tablets are dispensed in alternative packaging without the desiccant, the tablets will be stable for at least six months (or to the expiry date of the original container).
22 October 2015
IpocolSandoz Ltd
Sandoz Ltd
Ipocol
Tablets e/c 400mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light.
29 July 2015
SalofalkDr Falk Pharma UK Ltd
Dr Falk Pharma UK Ltd
Salofalk
Tablets e/c 250mg, 500mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light and moisture.
22 October 2015
PentasaFerring Pharmaceuticals Ltd
Ferring Pharmaceuticals Ltd
Pentasa
Tablets m/r 500mg, 1g
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers and protect from light. Discolouration (which is harmless) may occur outside packaging. Maximum one week in MCA.
22 October 2015
OctasaTillotts Pharma Ltd
Tillotts Pharma Ltd
Octasa
Tablets e/c m/r 400mg, 800mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light. SPC states store in original packaging. Company have stability studies that demonstrate stability in open storage for 30 days
22 October 2015
Lactation Safety Information
-
Synonym: Mesalamine
Moderate amount of published evidence of safety
Mesalazine has been associated with one confirmed and a small number of possible cases of diarrhoea in breastfed infants
Monitor infant for diarrhoea
29 June 2021